PURA syndrome
A rare genetic disorder affecting neurological development
Overview[edit | edit source]
PURA syndrome is a rare genetic disorder characterized by developmental delay, hypotonia, and neurological abnormalities. It is caused by mutations in the PURA gene, which plays a crucial role in the development and function of the nervous system. The condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
Genetics[edit | edit source]
PURA syndrome is associated with mutations in the PURA gene, located on chromosome 5. The gene encodes the purine-rich element binding protein A, which is involved in the regulation of DNA replication and RNA transcription. Mutations in this gene disrupt normal neurological development, leading to the symptoms observed in affected individuals.
Clinical Features[edit | edit source]
Individuals with PURA syndrome typically present with a range of neurological and developmental issues. Common features include:
- Developmental delay
- Hypotonia (reduced muscle tone)
- Seizures
- Intellectual disability
- Feeding difficulties
- Respiratory problems
Diagnosis[edit | edit source]
Diagnosis of PURA syndrome is based on clinical evaluation and genetic testing. Whole exome sequencing or targeted gene panels can identify mutations in the PURA gene, confirming the diagnosis.
Management[edit | edit source]
There is currently no cure for PURA syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Physical therapy to improve muscle tone and motor skills
- Occupational therapy to assist with daily living activities
- Speech therapy to address communication difficulties
- Anticonvulsant medications to control seizures
Prognosis[edit | edit source]
The prognosis for individuals with PURA syndrome varies depending on the severity of symptoms. While some individuals may achieve developmental milestones with support, others may have significant lifelong challenges.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD